243 related articles for article (PubMed ID: 30838737)
1. Effect of centre- and patient-related factors on uptake of haemodiafiltration in Australia and New Zealand: A cohort study using ANZDATA.
Mac K; Hedley J; Kelly PJ; Lee VW; Agar JWM; Hawley CM; Johnson DW; See EJ; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC
Nephrology (Carlton); 2020 Jan; 25(1):63-72. PubMed ID: 30838737
[TBL] [Abstract][Full Text] [Related]
2. Icodextrin use for peritoneal dialysis in Australia: A cohort study using Australia and New Zealand Dialysis and Transplant Registry.
Rangaswamy D; Guddattu V; Webster AC; Borlace M; Boudville N; Clayton P; Badve S; Johnson DW; Sud K
Perit Dial Int; 2020 Mar; 40(2):209-219. PubMed ID: 32063201
[TBL] [Abstract][Full Text] [Related]
3. Patient survival on haemodiafiltration and haemodialysis: a cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
See EJ; Hedley J; Agar JWM; Hawley CM; Johnson DW; Kelly PJ; Lee VW; Mac K; Polkinghorne KR; Rabindranath KS; Sud K; Webster AC
Nephrol Dial Transplant; 2019 Feb; 34(2):326-338. PubMed ID: 30124954
[TBL] [Abstract][Full Text] [Related]
4. Variability and trends over time and across centres in haemodialysis weekly duration in Australia and New Zealand.
Ethier I; Cho Y; Davies CE; Hawley CM; Campbell SB; Isbel NM; Pascoe EM; Polkinghorne KR; Roberts M; See EJ; Semple D; van Eps C; Viecelli AK; Johnson DW
Nephrology (Carlton); 2021 Feb; 26(2):153-163. PubMed ID: 33094549
[TBL] [Abstract][Full Text] [Related]
5. Inequity in dialysis related practices and outcomes in Aotearoa/New Zealand: a Kaupapa Māori analysis.
Huria T; Palmer S; Beckert L; Williman J; Pitama S
Int J Equity Health; 2018 Feb; 17(1):27. PubMed ID: 29458366
[TBL] [Abstract][Full Text] [Related]
6. Haemodialysis withdrawal in Australia and New Zealand: a binational registry study.
Chan S; Marshall MR; Ellis RJ; Ranganathan D; Hawley CM; Johnson DW; Wolley MJ
Nephrol Dial Transplant; 2020 Apr; 35(4):669-676. PubMed ID: 31397483
[TBL] [Abstract][Full Text] [Related]
7. Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
Shroff R; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu S; Bhowruth D; Borzych-Dużałka D; Bulut IK; Büscher R; Dempster C; Duzova A; Habbig S; Hayes W; Hegde S; Krid S; Licht C; Litwin M; Mayes M; Mir S; Nemec R; Obrycki L; Paglialonga F; Picca S; Ranchin B; Samaille C; Shenoy M; Sinha M; Smith C; Spasojevic B; Vidal E; Vondrák K; Yilmaz A; Zaloszyc A; Fischbach M; Schaefer F; Schmitt CP
BMC Nephrol; 2018 Aug; 19(1):199. PubMed ID: 30097064
[TBL] [Abstract][Full Text] [Related]
8. The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
Caskey FJ; Procter S; MacNeill SJ; Wade J; Taylor J; Rooshenas L; Liu Y; Annaw A; Alloway K; Davenport A; Power A; Farrington K; Mitra S; Wheeler DC; Law K; Lewis-White H; Ben-Shlomo Y; Hollingworth W; Donovan J; Lane JA
Trials; 2022 Jun; 23(1):532. PubMed ID: 35761367
[TBL] [Abstract][Full Text] [Related]
9. Social disparities in the prevalence of diabetes in Australia and in the development of end stage renal disease due to diabetes for Aboriginal and Torres Strait Islanders in Australia and Maori and Pacific Islanders in New Zealand.
Hill K; Ward P; Grace BS; Gleadle J
BMC Public Health; 2017 Oct; 17(1):802. PubMed ID: 29020957
[TBL] [Abstract][Full Text] [Related]
10. Increases in renal replacement therapy in Australia and New Zealand: understanding trends in diabetic nephropathy.
Grace BS; Clayton P; McDonald SP
Nephrology (Carlton); 2012 Jan; 17(1):76-84. PubMed ID: 21854505
[TBL] [Abstract][Full Text] [Related]
11. Obesity is a risk factor for peritonitis in the Australian and New Zealand peritoneal dialysis patient populations.
McDonald SP; Collins JF; Rumpsfeld M; Johnson DW
Perit Dial Int; 2004; 24(4):340-6. PubMed ID: 15335147
[TBL] [Abstract][Full Text] [Related]
12. A comparison of self-reported quality of life for an Australian haemodialysis and haemodiafiltration cohort.
Hill KE; Kim S; Crail S; Elias TJ; Whittington T
Nephrology (Carlton); 2017 Aug; 22(8):624-630. PubMed ID: 27253761
[TBL] [Abstract][Full Text] [Related]
13. Risk Predictors and Causes of Technique Failure Within the First Year of Peritoneal Dialysis: An Australia and New Zealand Dialysis and Transplant Registry (ANZDATA) Study.
See EJ; Johnson DW; Hawley CM; Pascoe EM; Badve SV; Boudville N; Clayton PA; Sud K; Polkinghorne KR; Borlace M; Cho Y
Am J Kidney Dis; 2018 Aug; 72(2):188-197. PubMed ID: 29277508
[TBL] [Abstract][Full Text] [Related]
14. Data quality of the Australia and New Zealand Dialysis and Transplant Registry: a pilot audit.
Gray NA; Mahadevan K; Campbell VK; Noble EP; Anstey CM
Nephrology (Carlton); 2013 Oct; 18(10):665-70. PubMed ID: 23841726
[TBL] [Abstract][Full Text] [Related]
15. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
[TBL] [Abstract][Full Text] [Related]
16. Predictors of renal recovery in Australian and New Zealand end-stage renal failure patients treated with peritoneal dialysis.
Craven AM; Hawley CM; McDonald SP; Rosman JB; Brown FG; Johnson DW
Perit Dial Int; 2007; 27(2):184-91. PubMed ID: 17299156
[TBL] [Abstract][Full Text] [Related]
17. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
[TBL] [Abstract][Full Text] [Related]
18. Low socio-economic status adversely effects dialysis survival in Australia.
Krishnasamy R; Gray NA
Nephrology (Carlton); 2018 May; 23(5):453-460. PubMed ID: 28383177
[TBL] [Abstract][Full Text] [Related]
19. Daily hemodialysis practices in Australia/New Zealand and in France: a comparative cohort study.
Pladys A; Bayat S; Couchoud C; Vigneau C; McDonald S
BMC Nephrol; 2019 May; 20(1):156. PubMed ID: 31064344
[TBL] [Abstract][Full Text] [Related]
20. Impact of estimated GFR reporting on late referral rates and practice patterns for end-stage kidney disease patients: a multilevel logistic regression analysis using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
Foote C; Clayton PA; Johnson DW; Jardine M; Snelling P; Cass A
Am J Kidney Dis; 2014 Sep; 64(3):359-66. PubMed ID: 24787762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
